Skip to content

13F-HR filed by SR One Capital Management, LP

SR One Capital Management, LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-13, with 11 holding rows worth $410,084,894.

Accession
0000950123-25-002049
Filed
2025-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 11 entries on the cover page, a total value of $410,084,894 stated on the cover page (in dollars after the unit check, H1), rows summing to $410,084,894 with VALUE read as dollars as filed, 13F file number 028-21964. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARCELLX INC COMMON STOCK03940C100Stock2,346,630$179,963,055dollars as filed
ARS PHARMACEUTICALS INC82835W108COM4,012,903$42,336,127dollars as filed
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock1,048,951$41,286,711dollars as filed
DESIGN THERAPEUTICS INC25056L103COM6,526,476$40,268,357dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock4,911,539$40,225,504dollars as filed
MINERALYS THERAPEUTICS INC603170101COM2,016,822$24,827,079dollars as filed
ALUMIS INC022307102COM1,959,896$15,404,782dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock430,330$8,344,099dollars as filed
NKARTA INC65487U108COMMON STOCK3,333,333$8,299,999dollars as filed
ENGENE HOLDINGS INC29286M105COM747,750$4,972,537dollars as filed
KALA BIO INC483119202COM NEW598,940$4,156,644dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-25-002049this filing2025-02-13acceptance time not in the bulk data set